RARE vs THR · rev $350.0M vs P/E 45, rev $498.2M
Ultragenyx (RARE) versus Thermon Group Holdings Inc (THR) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Thermon Group Holdings Inc (THR) is a specialty industrial machinery company listed on NYSE.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported THR revenue for 2025-03-31 was $498.2M. Net income was $53.5M. Revenue was up 0.7% from 2024-03-31 to 2025-03-31. THR currently screens at market cap $2.01B and trailing P/E 45.0.
RARE currently screens at market cap $2.79B. THR currently screens at market cap $2.01B and trailing P/E 45.0.
Not investment advice. Open the RARE and THR stock pages for the full models.
Not investment advice.